Table 2 Diagnostic efficacy of CEUS, RTE, and GOI-RADS alone and in combination
Pathological results | Sen(%) | Spe(%) | Accuracy(%) | PPV(%) | NPV(%) | |||
|---|---|---|---|---|---|---|---|---|
Benign (n=18) | Malignancy (n=86) | |||||||
Elastic score | 81.4 | 66.67 | 78.85 | 92.11 | 42.86 | |||
1–2 | 12 | 16 | ||||||
3–4 | 6 | 70 | ||||||
CEUS | 91.86 | 61.11 | 86.54 | 91.86 | 61.11 | |||
Benign | 11 | 7 | ||||||
Malignancy | 7 | 79 | ||||||
GOI-RADS | 81.4 | 61.11 | 77.88 | 90.91 | 40.74 | |||
1–3 | 11 | 16 | ||||||
4 | 7 | 70 | ||||||
RTE + CEUS | ||||||||
Benign | 8 | 0 | 100 | 44.44 | 90.38 | 89.58 | 100 | |
Malignancy | 10 | 86 | ||||||
RTE + GOI-RADS | ||||||||
Benign | 10 | 4 | 95.35 | 55.56 | 88.46 | 91.11 | 71.43 | |
Malignancy | 8 | 82 | ||||||
CEUS + GOI-RADS | ||||||||
Benign | 8 | 3 | 96.51 | 44.44 | 87.50 | 89.25 | 72.73 | |
Malignancy | 10 | 83 | ||||||
RTE + CEUS + GOI-RADS | ||||||||
Benign | 7 | 0 | 100 | 38.89 | 89.42 | 88.67 | 100 | |
Malignancy | 11 | 86 | ||||||